A 48 week, d/b [double-blind], d/d [double dummy], randomised, m/n [multinational], m/c [multicentre], 2 arm, p/g [parallel group] clinical study of fixed combination beclomethasone diproprionate + formoterol fumarate via PMDI [pressurised metered dose inhaler] with HFA-134a propellant vs budesonide + formoterol DPI [dry powder inhaler] vs formoterol DPI in stable severe COPD [chronic obstructive pulmonary disease]
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 07 Mar 2007
At a glance
- Drugs Beclometasone/formoterol; Budesonide; Formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 07 Mar 2007 New trial record.